used in common Chinese, Ayurvedic, and Thai drugs. Conolidine could stand for the beginning of a new period of Continual pain administration. Now it is being investigated for its outcomes on the atypical chemokine receptor (ACK3). In a rat product, it had been identified that a competitor molecule binding to ACKR3 resulted in inhibition of ACKR3’